Add Row
Add Element
cropper
update
Lush Skin Insider
update
Add Element
  • Home
  • Categories
    • Experts Talks
    • Myth Busters
    • Research Insights
    • Routine Guides
    • Product Picks
Add Row
Add Element
April 09.2025
3 Minutes Read

Revolutionizing Facial Redness Measurement: Introducing The Kesty Redness Scale

Close-up showing facial erythema, Kesty Redness Scale assessment.

Revamping Erythema Assessment: The Kesty Redness Scale

The beauty and dermatology industries continually evolve, necessitating new methodologies for accurately measuring skin conditions. The Kesty Redness Scale (KRS) offers a solution by providing a standardized, five-point grading system to assess facial erythema. As highlighted in a recent study published in the Journal of Cosmetic Dermatology, the KRS addresses a pressing gap in cosmetic dermatology where existing grading systems often fail.

Understanding Facial Erythema Management

Facial erythema, or redness of the skin, can result from various conditions, including acne, rosacea, or after cosmetic procedures. Traditionally, dermatologists have lacked a reliable tool for objectively measuring this redness across treatments. The KRS fills this void, allowing practitioners to quantify improvements, making it easier for patients and providers to gauge treatment effectiveness.

Research Insights: Robust Study and Findings

In a prospective observational study, researchers enlisted ten professionals, including board-certified dermatologists and plastic surgeons, to evaluate over 100 facial photographs using the KRS. The findings revealed impressive inter-rater reliability among evaluators, underscoring the scale's credibility. Analytical metrics such as Gwet’s AC2 and Kendall's W indicated a strong agreement among clinicians, enhancing confidence in its application.

The KRS in Everyday Practice: Feasibility and Impact

Evaluators not only found the KRS intuitive but also expressed a strong willingness to integrate it into their routine clinical practices. This shift could improve decision-making for treatment plans and enhance patient education on expected outcomes. With the prevalence of social media and beauty influencers, the accurate portrayal of skin conditions can also bridge the gap between professional care and public perception.

Potential Implications on Cosmetic Dermatology

For the target audience of adults aged 25-45, primarily women with disposable income, the increased precision in dermatology assessments means more informed choices in skincare routines. As consumers become more aware of evidence-based practices, tools like the KRS are vital in debunking myths about skincare treatments, ensuring valid and trustworthy guidance for aesthetic decisions.

Towards Future Innovations in Dermatology

The Kesty Redness Scale is not an isolated development. As technology advances, we anticipate new tools that enhance aesthetic practices and patient outcomes. Dermatologists, leveraging technological innovations like these, can set benchmarks for assessing various skin conditions, thus paving the way for improved therapies and heightened patient satisfaction.

What This Means for Patients and Practitioners

The arrival of the KRS signifies a pivotal shift in how erythema is quantified in clinical settings. For patients, understanding their skin's conditions and treatment options based on objective metrics fosters a more engaged and informed client-practitioner relationship. Practitioners, on the other hand, can rely on validated tools to substantiate their assessments, enhancing their credibility and effectiveness.

Conclusion: Why You Should Know About the KRS

As cosmetic dermatology advances, being informed about tools like the Kesty Redness Scale can empower consumers and practitioners alike. By recognizing the significance of standardized measures in skincare, both parties can cultivate a more reliable, data-driven dialogue surrounding facial erythema. Stay informed and make empowered choices in your skincare journey.

Research Insights

Write A Comment

*
*
Related Posts All Posts
06.14.2025

Discover How Gua Sha and Facial Rollers Transform Skin Health

Update Unlocking Skin Health: The Science Behind Gua Sha and Facial Rollers In recent days, a significant study has come to light regarding at-home facial massage methods that have piqued the interest of skincare enthusiasts. The findings suggest that both gua sha and facial rollers can positively enhance one’s skin elasticity, tone, and contour after using them for eight weeks. For many adults, especially women aged 25 to 45, the quest for youthful, vibrant skin often leads to exploring various beauty trends. Yet, understanding the science behind these rituals may help users achieve better results and navigate the plethora of available products. Comprehensive Sun Protection: A Necessity for All Skin Types Another critical topic highlighted by experts is the spectrum of sun damage—one that extends beyond traditional UV rays. Susan Taylor, MD, FAAD, accentuates the importance of comprehensive sun protection that incorporates both visible and infrared light, particularly for darker skin tones. This insight is crucial as many ignore the broader impacts of sun exposure, leading to hyperpigmentation and other skin concerns that could be easily mitigated through informed decision-making on skincare. The Role of Psychosocial Support in Hidradenitis Suppurativa Care Hidradenitis suppurativa (HS) has emerged as a focus of discussion, emphasizing not only the physical treatment of skin conditions but also the mental and emotional wellness of patients. Dr. Adam Friedman highlights that psychosocial support plays a vital role in HS care, citing HS Connect—a platform aiding those suffering from the condition. This evolution in skincare treatment aligns closely with the growing recognition of holistic health approaches in dermatology, providing a more comprehensive view of patient care. What This Means for Your Skincare Routine Given these insights, consumers should be proactive in adopting effective skincare regimens. Utilizing gua sha or facial rollers can be beneficial, but it becomes essential to emphasize the importance of sun protection tailored specifically for one's skin type. This will not only help in achieving immediate aesthetic goals but also safeguard skin health in the long run. Taking Charge of Your Skin: Actionable Insights and Tips Consumers are now well-equipped to take charge of their skincare beyond simple beauty routines. Start incorporating scientifically-backed methods such as using gua sha and facial rollers regularly while prioritizing sun protection strategies that consider all light spectrums. Moreover, advocate for mental health support within dermatological care, as it is also a critical aspect of overall skin health. To stay updated on the latest in dermatology and skincare innovations, consider subscribing to Dermatology Times for weekly insights and expert advice.

06.13.2025

Unlocking Dermatology Insights: Research Breakthroughs and Innovations

Update Fresh Insights on Psoriasis Management The dermatological landscape is ever-evolving, and with it, the strategies employed to manage skin conditions such as generalized pustular psoriasis (GPP). Initiated by Dr. Aaron Farberg, experts gathered to unravel the complexities surrounding GPP, highlighting the promise of targeted therapies. These new treatment approaches not only reflect a growing understanding of the disease pathology but also demonstrate the potential for improved patient outcomes. Gaining Ground in Urticaria Trials On the clinical research frontier, Alys Pharmaceuticals has made strides in the battle against cold urticaria. Their recent submission for a clinical trial application in Germany aims at evaluating ALY-301, a selective c-Kit inhibitor for the chronic inducible urticaria (CIndU) subtype. These developments are significant as they address a condition that often lacks effective treatment options, emphasizing the need for continued innovation in dermatology. Unraveling the Complexities of Vitiligo Groundbreaking studies have identified five distinct clinical subtypes of vitiligo, a revelation poised to alter therapeutic approaches among practitioners. By understanding these subtypes, dermatologists can tailor interventions more effectively, leading to better patient satisfaction and treatment efficacy. Patient education regarding these subtypes can enhance trust and engagement in the therapeutic process. Key Takeaways from the 2025 Fall Clinical PA/NP Conference With the recent Fall Clinical PA/NP Conference in Orlando, valuable insights emerged from expert Jamie Restivo, MPAS, PA-C. Her observations underscored emerging therapies and contemporary treatment protocols that will likely influence practice in the coming years. Such conferences are pivotal as they facilitate knowledge exchange, ensuring that practitioners stay abreast of the latest advancements in dermatological treatment. Combining Innovations for Hair Restoration The synergy between Cuticapil stem hair serum and minoxidil has shown promise in mitigating hair loss. A real-world study reported notable improvements in hair density when both treatments were utilized concurrently. This combination therapy could offer hope to many struggling with thinning hair, emphasizing the importance of multi-modal approaches in dermatological care. Addressing Men's Health Concerns: A Candid Approach In recognition of Men's Health Month, Dr. Hershel Dobkin, FAAD, tackled the often-ignored issue of genital health in men. His guidance serves as an essential reminder for patients about healthier dialogues surrounding vulnerable topics. By promoting discussions about male genital concerns, physicians can enhance patient comfort and ultimately lead to more proactive health management. Reflections from the Revolutionizing Atopic Dermatitis Conference Dr. Maureen Offiah, a participant at the RAD 2025 Conference, provided reflections on cutting-edge treatments for atopic dermatitis. Her insights into emerging therapies not only bring awareness to this pervasive condition but also emphasize the importance of continuous education in dermatology. Attending such conferences allows healthcare providers to remain informed and proficient in patient care. As dermatology continues to advance, staying updated with the latest research, clinical trials, and expert insights is vital for both practitioners and patients. Engaging with leading-edge developments, such as those noted above, will guide skincare choices that align with modern scientific understanding. For those invested in their skincare journeys, following these advancements can lead to more effective, personalized dermatological care. To keep up with ongoing changes in dermatological practice, including new treatments and clinical insights, consider subscribing to Dermatology Times for weekly updates. Staying informed helps ensure that both healthcare providers and patients benefit from the latest in skin health advancements.

06.12.2025

Innovative Skincare Breakthroughs Everyone Needs to Know on June 11, 2025

Update Revolutionizing Skincare: The Latest Insights from June 11, 2025 On June 11, 2025, dermatology professionals gathered insights from the latest studies, unveiling exciting advancements in the field. The focus on injectable hyaluronic acid reveals promising results in skin improvement, offering a glimpse into future therapies that may enhance skincare routines, especially for those seeking higher quality and effective solutions. The Rising Burden of Chronic Spontaneous Urticaria The increasing awareness around chronic spontaneous urticaria (CSU) informs us not only about the ongoing patient struggles but also about emerging treatment options. Advancements in understanding the psychological impact and physical burden of CSU have motivated researchers to develop more effective therapies tailored to individual patient needs. Addressing both the physical symptoms and emotional well-being could offer a holistic approach for those affected by this condition. Long-Term Power of Bimekizumab Unveiled At the 2025 EULAR meeting, the significance of long-term data on bimekizumab for psoriatic arthritis (PsA) enthusiasts was emphasized. Three years of data presented by UCB reveals how bimekizumab can improve outcomes over time, establishing its place in dermatologic therapy for PsA. Patients and practitioners alike can feel confident in its potential to manage chronic conditions more effectively long-term. Plant-Derived Innovations: The Future of Regenerative Skincare Dr. Frank Roesken's groundbreaking work with plant-derived exosomes has positioned Skin Moderne at the forefront of regenerative skincare. This plant-derived innovation has potential applications for restorative treatments in skincare, reshaping how patients and clinicians approach skin rejuvenation. Understanding how these exosomes work at a cellular level allows for an educated conversation about their integration into everyday skincare routines. Tremfya: Pioneering Structural Damage Prevention Exciting outcomes from the EULAR 2025 presented by the Tremfya team shed light on its unprecedented efficacy in inhibiting joint structural damage in PsA patients. This advancement not only marks a significant step forward for psoriatic arthritis management but also showcases the crucial nature of understanding inflammation’s broader implications on skin and joint health, bridging connections between dermatology and rheumatology. Positive Outcomes in Skin of Color: A Step Towards Inclusivity Late-breaking data at RAD 2025 emphasized the success of dupilumab as a monotherapy for patients with atopic dermatitis (AD) with skin of color. The DISCOVER trial results offer hope for improved management of moderate to severe AD symptoms, highlighting the necessity for inclusive studies that reflect diverse populations. Understanding how different skin types respond to treatments is crucial for developing universally effective skincare. The Importance of Staying Informed For those invested in evidence-based skincare, staying updated with the evolving landscape of dermatological research is cardinal. The advances discussed at the recent conferences not only reflect the potential for improved treatment options but also the necessity for informed decisions in one’s skincare regimen. The journey of skin health is stepped back into an engaging narrative that provides actionable insights. Conclusion: Embracing Innovation in Skincare The insights from dermatological advancements on June 11, 2025, underscore a riveting era in skincare innovation. By remaining informed and educated on the latest therapies and technologies, patients and healthcare professionals can create an empowered dialogue on skin health management. As consumers, it’s essential to seek products that incorporate these advancements for effective and trustworthy skincare solutions. Keep abreast of ongoing developments and consider how these breakthroughs can enhance your skincare routine today.

Add Row
Add Element
cropper
update
MYBRANDINGLOGO
cropper
update

  • update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

ABOUT US

Our goal is to become a trusted voice in the cluttered skincare industry, following the “Science over trends” and bridging the gap between cosmetic dermatology and evidence-based skincare.

We offer dermatologist-backed advice, simplifying complex medical research into actionable tips. This focus directly combats misinformation and meets the demand for credible skincare guidance.
 
Our team of experienced reporters is committed to bring you expert-backed articles, dermatologists' insights, and myth-busting content that targets misinformation, delivered to you in easy-to-digest format like infographics, explainer videos, podcasts, interviews, breaking down medical research into actionable tips for skin health.

{"company":"Lush Skin Insider","address":"-","city":"Vernon Hills","state":"IL","zip":"60061","email":"mh.mailq@gmail.com","tos":"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","privacy":"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"}
Add Row
Add Element

© 2025 Lush Skin Insider All Rights Reserved. -, Vernon Hills, IL 60061 . Contact Us . Terms of Service . Privacy Policy

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*